Vimarsana
Biggest News Aggregation in the World

Page 9 - Confidence Interval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Confidence Interval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Confidence Interval Today - Breaking & Trending Today

The 2 Minute Medicine Podcast Episode 37 | 2 Minute Medicine - Vimarsana News

The 2 Minute Medicine Podcast Episode 37 | 2 Minute Medicine

Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in healthcare news and research evidence. Our episode is live! Episode Description We begin with a discussion about our article of the week entitled “Electronic nicotine delivery

European Commission Expands Approval of Bristol Myers Squibb's Reblozyl® (luspatercept) to Include First-Line Treatment of Transfusion-Dependent Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (LR-MDS) -April 02, 2024 at 08:09 pm EDT - Vimarsana News

European Commission Expands Approval of Bristol Myers Squibb's Reblozyl® (luspatercept) to Include First-Line Treatment of Transfusion-Dependent Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (LR-MDS) -April 02, 2024 at 08:09 pm EDT

Approval of Reblozyl is based on head-to-head, pivotal Phase 3 COMMANDS study, in which Reblozyl nearly doubled the percentage of patients achieving transfusion independence and hemoglobin increase,...

FDA Approves TriClip TEER System for Tricuspid Regurgitation - Vimarsana News

FDA Approves TriClip TEER System for Tricuspid Regurgitation

Less than 2 months after being the subject of an FDA AdComm meeting, Abbott's TriClip TEER System has received approval for tricuspid regurgitation.

REDUCE-IT Lp(a) Analysis Details Icosapent Ethyl Effect on MACE Across Lp(a) Range - Vimarsana News

REDUCE-IT Lp(a) Analysis Details Icosapent Ethyl Effect on MACE Across Lp(a) Range

A REDUCE-IT analysis highlights consistent cardiovascular benefits with icosapent ethyl across varying levels of Lp(a).

Lazy Eye in Children Could Predict Cardiovascular, Metabolic Risk Later in Life - Vimarsana News

Lazy Eye in Children Could Predict Cardiovascular, Metabolic Risk Later in Life

Study links childhood amblyopia with increased risk of cardiometabolic dysfunction in adulthood.